Serum mid-regional pro-atrial natriuretic peptide (MR-proANP) and pro-adrenomedullin (MR-proADM) are novel biomarkers for acute heart failure (AHF). Like other AFH biomarkers, the performance of these tests are affected by the presence of clinical variables such as renal failure and obesity. In a substudy of the Biomarkers from Acute Heart Failure Study, we show that diabetes did not influence the performance of these markers with regards to AHF diagnosis or 90-day all cause death. However, in patients without AHF, increased MR-proADM alone was associated with the presence of diabetes. © 2012 Informa UK, Ltd.

The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea / Alan H. b., Wu; Jeffrey, Tabas; Johnathan, Stein; Mihael, Potocki; Christian, Mueller; Mccord, James; Richards, Mark; Hartmann, Oliver; Richard, Nowak; W., Frank Peacock; Piotr, Ponikowski; Moeckel, Martin; Hogan, Christopher; Gerasimos S., Filippatos; DI SOMMA, Salvatore; Anand, Inder; Ng, Leong; Sean Xavier, Neath; Robert, Christenson; Nils G., Morgenthaler; Stefan D., Anker; Alan S., Maisel. - In: BIOMARKERS. - ISSN 1354-750X. - STAMPA. - 17:6(2012), pp. 490-497. [10.3109/1354750x.2012.687014]

The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea

DI SOMMA, Salvatore;
2012

Abstract

Serum mid-regional pro-atrial natriuretic peptide (MR-proANP) and pro-adrenomedullin (MR-proADM) are novel biomarkers for acute heart failure (AHF). Like other AFH biomarkers, the performance of these tests are affected by the presence of clinical variables such as renal failure and obesity. In a substudy of the Biomarkers from Acute Heart Failure Study, we show that diabetes did not influence the performance of these markers with regards to AHF diagnosis or 90-day all cause death. However, in patients without AHF, increased MR-proADM alone was associated with the presence of diabetes. © 2012 Informa UK, Ltd.
2012
heart failure; mid-regional pro-adrenomedullin; mid-regional pro-atrial natriuretic peptide; risk stratification; risk stratification.
01 Pubblicazione su rivista::01a Articolo in rivista
The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea / Alan H. b., Wu; Jeffrey, Tabas; Johnathan, Stein; Mihael, Potocki; Christian, Mueller; Mccord, James; Richards, Mark; Hartmann, Oliver; Richard, Nowak; W., Frank Peacock; Piotr, Ponikowski; Moeckel, Martin; Hogan, Christopher; Gerasimos S., Filippatos; DI SOMMA, Salvatore; Anand, Inder; Ng, Leong; Sean Xavier, Neath; Robert, Christenson; Nils G., Morgenthaler; Stefan D., Anker; Alan S., Maisel. - In: BIOMARKERS. - ISSN 1354-750X. - STAMPA. - 17:6(2012), pp. 490-497. [10.3109/1354750x.2012.687014]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/471427
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact